Effect of curcumin on lifespan, activity pattern, oxidative stress, and apoptosis in the brains of transgenic drosophila model of Parkinson's disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Siddique, Yasir Hasan ^a   Naz, Falaq ^a   Jyoti, Smita ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; ALCOHOL; ALPHA SYNUCLEIN; CARBONYL DERIVATIVE; CURCUMIN; DOPAMINE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; BRAIN HOMOGENATE; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL PARKINSONISM; FEMALE; FRUIT FLY MODEL; HUMAN; LIFESPAN; LIPID PEROXIDATION; LIPID PEROXIDATION ASSAY; MALE; NONHUMAN; OXIDATIVE STRESS; TRANSGENIC DROSOPHILA; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DOSE RESPONSE; DROSOPHILA MELANOGASTER; DRUG EFFECTS; GENETICS; LONGEVITY; METABOLISM; PARKINSON DISEASE; PATHOLOGY; SURVIVAL; TRANSGENIC ANIMAL; TREATMENT OUTCOME;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; BEHAVIOR, ANIMAL; CURCUMIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DROSOPHILA MELANOGASTER; HUMANS; LONGEVITY; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; SURVIVAL; TREATMENT OUTCOME;

EID: 84900026819     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/606928     Document Type: Article

References (53)

1. Feany M. B., Bender W. W., A Drosophila model of Parkinson's disease. Nature 2000 404 6776 394 398 2-s2.0-0034704752 10.1038/35006074
2. Uversky V. N., Li J., Souillac P., Millett I. S., Doniach S., Jakes R., Goedert M., Fink A. L., Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of α -synuclein assembly by β-and γ -synucleins. Journal of Biological Chemistry 2002 277 14 11970 11978 2-s2.0-0037023699 10.1074/jbc.M109541200
3. Celotto A. M., Palladino M. J., Drosophila: a "model" model system to study neurodegeneration. Molecular Interventions 2005 5 5 292 303 2-s2.0-27744499911 10.1124/mi.5.5.9
4. Muñoz-Soriano V., Paricio N., Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies. Parkinson's Disease 2011 2011 14 2-s2.0-79955101548 10.4061/2011/520640 520640
5. Naoi M., Maruyama W., Future of neuroprotection in Parkinson's disease. Parkinsonism and Related Disorders 2001 8 2 139 145 2-s2.0-0034899354 10.1016/S1353-8020(01)00028-1
6. Lü J.-M., Nurko J., Weakley S. M., Jiang J., Kougias P., Lin P. H., Yao Q., Chen C., Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Medical Science Monitor 2010 16 5 RA93 RA100 2-s2.0-77954288819
7. Long J., Gao H., Sun L., Liu J., Zhao-Wilson X., Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila parkinson's disease model. Rejuvenation Research 2009 12 5 321 331 2-s2.0-70450285045 10.1089/rej.2009.0877
8. Stagos D., Amougias G., Matakos A., Spyrou A., Tsatsakis A. M., Kouretas D., Chemoprevention of liver cancer by plant polyphenols. Food and Chemical Toxicology 2012 50 6 2155 2170 2-s2.0-84860332038 10.1016/j.fct.2012.04.002
9. Chattopadhyay I., Biswas K., Bandyopadhyay U., Banerjee R. K., Turmeric and curcumin: biological actions and medicinal applications. Current Science 2004 87 1 44 53 2-s2.0-6444221181
10. Siddique Y. H., Ara G., Jyoti S., Afzal M., Protective effect of curcumin in transgenic Drosophila melanogaster model of Parkinson's disease. Alternative Medicine Studies 2012 2, article e3 7 9
11. Siddique Y. H., Ara G., Jyoti S., Afzal M., The dietary supplementation of nordihydroguaiaretic acid (NDGA) delayed the loss of climbing ability in Drosophila model of Parkinson's disease. Journal of Dietary Supplements 2012 9 1 1 8 2-s2.0-84857419171 10.3109/19390211.2011.630716
12. Siddique Y. H., Naz F., Jyoti S., Afzal M., Protective effect of apigenin in transgenic Drosophila melanogaster model of parkinson's disease. Pharmacologyonline 2011 3 790 795 2-s2.0-84856186262
13. Chiu J. C., Low K. H., Pike D. H., Yildirim E., Edery I., Assaying locomotor activity to study circadian rhythms and sleep parameters in Drosophila. Journal of Visualized Experiments 2010 43 2-s2.0-80055103245 10.3791/2157 e2157
14. Rosato E., Kyriacou C. P., Analysis of locomotor activity rhythms in Drosophila. Nature Protocols 2006 1 2 559 568 2-s2.0-33947527133 10.1038/nprot.2006.79
15. Siddique Y. H., Mujtaba S. F., Jyoti S., Naz F., GC-MS analysis of Eucalyptus citriodora leaf extract and its role on the dietary supplementation in transgenic Drosophila model of Parkinson's disease. Food and Chemical Toxicology 2013 55 29 35 10.1016/j.fct.2012.12.028
16. Hawkins C. L., Morgan P. E., Davies M. J., Quantification of protein modification by oxidants. Free Radical Biology and Medicine 2009 46 8 965 988 2-s2.0-63049127289 10.1016/j.freeradbiomed.2009.01.007
17. Mitchell K. J., Staveley B. E., Protocol for the detection and analysis of cell death in the adult Drosophila brain. Drosophila Information Services 2006 93 118 121
18. Giasson B. I., Ischiropoulos H., Lee V. M.-Y., Trojanowski J. Q., The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radical Biology and Medicine 2002 32 12 1264 1275 2-s2.0-0037096193 10.1016/S0891-5849(02)00804-3
19. Dauer W., Przedborski S., Parkinson's disease: mechanisms and models. Neuron 2003 39 6 889 909 2-s2.0-0141741347 10.1016/S0896-6273(03)00568-3
20. Abbott R. A., Cox M., Markus H., Tomkins A., Diet, body size and micronutrient status in Parkinson's disease. European Journal of Clinical Nutrition 1992 46 12 879 884 2-s2.0-0027062690
21. Ray B., Bisht S., Maitra A., Maitra A., Lahiri D. K., Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc) in the neuronal cell culture and animal model: implications for Alzheimer's disease. Journal of Alzheimer's Disease 2011 23 1 61 77 2-s2.0-78651377254 10.3233/JAD-2010-101374
22. Khan S., Jyoti S., Naz F., Shakya B., Rahul, Afzal M., Siddique Y. H., Effect of L-ascorbic acid on the climbing ability and protein levels in the brain of Drosophila model of Parkinson's disease. International Journal of Neurosciences 2012 122 704 709 10.3109/00207454.2012.709893
23. Siddique Y. H., Jyoti S., Naz F., Effect of epicatechin gallate dietary supplementation on transgenic Drosophila model of Parkinson's disease. Journal of Dietary Supplements 2014 11 2 121 130 10.3109/19390211.2013.859207
24. Siddique Y. H., Ara G., Jyoti S., Afzal M., Effect of capsaicin on the climbing ability in Drosophila model of Parkinson's disease. The American Journal of Drug Discovery and Development 2012 2 1 50 54 2-s2.0-84856822866 10.3923/ajdd.2012.50.54
25. Pal R., Miranda M., Narayan M., Nitrosative stress-induced Parkinsonian Lewy-like aggregates prevented through polyphenolic phytochemical analog intervention. Biochemical and Biophysical Research Communications 2011 404 1 324 329 2-s2.0-78650881856 10.1016/j.bbrc.2010.11.117
26. Youdim K. A., Joseph J. A., A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radical Biology and Medicine 2001 30 6 583 594 2-s2.0-0035868503 10.1016/S0891-5849(00)00510-4
27. Vauzour D., Vafeiadou K., Rodriguez-Mateos A., Rendeiro C., Spencer J. P. E., The neuroprotective potential of flavonoids: a multiplicity of effects. Genes and Nutrition 2008 3 115 126 2-s2.0-53949125715 10.1007/s12263-008-0091-4
28. Qualls Z., Brown D., Ramlochansingh C., Hurley L. L., Tizabi Y., Protective effects of curcumin against rotenone and salsolinnol-induced toxicity: implications for Parkinson's disease. Neurotoxicity Research 2014 25 81 89 10.1007/s12640-013-9433-0
29. Prasad S. N., Muralidhara, Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster. Relevance to neuropathy. Journal of Insect Physiology 2014 60 7 16 10.1016/j.jinsphys.2013.10.003
30. Bieschke J., Russ J., Friedrich R. P., Ehrnhoefer D. E., Wobst H., Neugebauer K., Wanker E. E., EGCG remodels mature α -synuclein and amyloid- β fibrils and reduces cellular toxicity. Proceedings of the National Academy of Sciences of the United States of America 2010 107 17 7710 7715 2-s2.0-77952346781 10.1073/pnas.0910723107
31. Masuda T., Maekawa T., Hidaka K., Bando H., Takeda Y., Yamaguchi H., Chemical studies on antioxidant mechanism of curcumin: analysis of oxidative coupling products from curcumin and linoleate. Journal of Agricultural and Food Chemistry 2001 49 5 2539 2547 2-s2.0-0034843535 10.1021/jf001442x
32. Joe B., Lokesh B. R., Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochimica et Biophysica Acta 1994 1224 2 255 263 2-s2.0-0028134769 10.1016/0167-4889(94)90198-8
33. Ryter S. W., Kim H. P., Hoetzel A., Park J. W., Nakahira K., Wang X., Choi A. M., Mechanism of cell death in oxidative stress. Anti-Oxidant Radical Signal 2007 9 49 89
34. Chan W.-H., Wu H.-J., Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells. Journal of Cellular Biochemistry 2004 92 1 200 212 2-s2.0-15044365453 10.1002/jcb.20059
35. Zbarsky V., Datla K. P., Parkar S., Rai D. K., Aruoma O. I., Dexter D. T., Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radical Research 2005 39 10 1119 1125 2-s2.0-25444508963 10.1080/10715760500233113
36. Wang M. S., Boddapati S., Emadi S., Sierks M. R., Curcumin reduces α -synuclein induced cytotoxicity in Parkinson's disease cell model. BMC Neuroscience 2010 11, article 57 2-s2.0-77951557863 10.1186/1471-2202-11-57
37. Ono K., Yamada M., Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α -synuclein fibrils in vitro. Journal of Neurochemistry 2006 97 1 105 115 2-s2.0-33644945380 10.1111/j.1471-4159.2006.03707.x
38. Gadad B. S., Subramanya P. K., Pullabhatla S., Shantharam I. S., Rao K. S., Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α -Synuclein oligomer formation: relevance to Parkinson's disease. Current Pharmaceutical Design 2012 18 1 76 84 2-s2.0-84855849474 10.2174/ 138161212798919093
39. Lee K.-S., Lee B.-S., Semnani S., Avanesian A., Um C.-Y., Jeon H.-J., Seong K.-M., Yu K., Min K.-J., Jafari M., Curcumin extends life span, improves health span, and modulates the expression of age-associated aging genes in Drosophila melanogaster. Rejuvenation Research 2010 13 5 561 570 2-s2.0-78650036223 10.1089/rej.2010.1031
40. Soh J. W., Marowsky N., Nichols T. J., Rahman A. M., Miah T., Sarao P., Khasawneh R., Unnikrishnan A., Heydari A. R., Silver R. B., Arking R., Curcumin is an early-acting stage-specific inducer of extended functional longevity in Drosophila. Experimental Gerontology 2013 48 299 239
41. Strong R., Miller R. A., Astle C. M., Baur J. A., de Cabo R., Fernandez E., Guo W., Javors M., Kirkland J. L., Nelson J. F., Sinclair D. A., Teter B., Williams D., Zaveri N., Nadon N. L., Harrison D. E., Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid and medium-chain triglyceride oil on life span of genetically heterogenous mice. The Journals of Gerontology A, Biological Sciences and Medical Sciences 2013 68 6 16 10.1093/gerona/gls070
42. Liao V. H.-C., Yu C.-W., Chu Y.-J., Li W.-H., Hsieh Y.-C., Wang T.-T., Curcumin-mediated lifespan extension in Caenorhabditis elegans. Mechanisms of Ageing and Development 2011 132 10 480 487 2-s2.0-80053385974 10.1016/j.mad.2011.07.008
43. Bala K., Tripathy B. C., Sharma D., Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology 2006 7 2 81 89 2-s2.0-33745457596 10.1007/s10522-006-6495-x
44. Mythri R. B., Srinivas Bharath M. M., Curcumin: a potential neuroprotective agent in Parkinson's disease. Current Pharmaceutical Design 2012 18 1 91 99 2-s2.0-84855858783 10.2174/138161212798918995
45. Siddique Y. H., Khan W., Singh B. R., Naqvi A. H., Synthesis of alginate-curcumin nanocomposite and its protective role in transgenic Drosophila model of parkinson's disease. ISRN Pharmocology 2013 2013 8 794582 10.1155/2013/794582
46. Xiang L., Nakamura Y., Lim Y.-M., Yamasaki Y., Kurokawa-Nose Y., Maruyama W., Osawa T., Matsuura A., Motoyama N., Tsuda L., Tetrahydrocurcumin extends life span and inhibits the oxidative stress response by regulating the FOXO forkhead transcription factor. Aging 2011 3 11 1098 1109 2-s2.0-83755225709
47. Zhao J., Yu S., Zheng W., Feng G., Luo G., Wang L., Zhao Y., Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochemical Research 2010 35 3 374 379 10.1007/s11064-009-0065-y
48. α kinase and Akt activation. Molecular Pharmacology 2006 69 1 195 206 2-s2.0-30044446136 10.1124/mol.105.017400
49. Aktas C., Kanter M., Erboga M., Ozturk S., Anti-apoptotic effects of curcumin on cadmium-induced apoptosis in rat testes. Toxicology and Industrial Health 2012 28 2 122 130 2-s2.0-84859018306 10.1177/0748233711407242
50. Toydemir T., Kanter M., Erboga M., Oguz S., Erenoglu C., Antioxidative, antiapoptotic, and proliferative effect of curcumin on liver regeneration after partial hepatectomy in rats. Journal of Toxicology and Industrial Health 2013 10.1177/0748233712469658
51. Reuter S., Eifes S., Dicato M., Aggarwal B. B., Diederich M., Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochemical Pharmacology 2008 76 11 1340 1351 2-s2.0-55949095821 10.1016/j.bcp.2008.07.031
52. Prasad K. N., Hernandez C., Edwards-Prasad J., Nelson J., Borus T., Robinson W. A., Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon- α 2b on human melanoma cells in culture by a mixture of vitamins. Nutrition and Cancer 1994 22 3 233 245 2-s2.0-0027996576
53. Pendleton R. G., Parvez F., Sayed M., Hillman R., Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. Journal of Pharmacology and Experimental Therapeutics 2002 300 1 91 96 2-s2.0-0036137083 10.1124/jpet.300.1.91